Paid Clinical Trials in Carmel, IN
As of June 2026, 89 paid clinical trials are recruiting in Carmel, Indiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Carmel offers studies at sites including IU Health North Hospital for conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Carmel
Trials by drug in Carmel
Filter results
89 clinical trials
↓ Download CSVMulti-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Pilot Randomized Clinical Trial of Informational Support Versus Spiritual Care
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Rapid Evacuation and Access of Cerebral Hemorrhage Trial
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
PerQdisc Traditional Feasibility Trial.
Post-Operative Thoracolumosacral Orthosis for PJK
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
About research studies in Carmel
Carmel has approximately 89 recruiting research studies across a wide range of therapeutic areas. Indiana hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Carmel
Researchers run research studies in Carmel, IN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| IU Health North Hospital | Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 26 |
| Midwest Eye Institute | Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Edema Secondary to Inflammation, Geographic Atrophy | 6 |
| IU Health Joe and Shelly Schwarz Cancer Center | Breast Cancer, Estrogen-receptor-low Breast Cancer, HPV Positive Cancer | 5 |
| Indiana Spine Group | Adult Spinal Deformity Surgery, Degenerative Disc Disease, Discogenic Low Back Pain | 4 |
| Associated Vitreoretinal and Uveitis Consultants | Age-Related Macular Degeneration, Choroidal Neovascularization, Geographic Atrophy | 3 |
| Midwest Cornea Associates, LLC | Limbal Stem Cell Deficiency, Corneal Scar | 3 |
| Ascension St. Vincent Cardiovascular Research Institute | Coronary Artery Disease | 2 |
| Ascension St. Vincent Heart Center | Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Insufficiency | 2 |
| Associated Vitreoretinal and Uveitis Consultants LLC | Macular Edema Secondary to Inflammation | 2 |
| Goodman Campbell Brain and Spine | Brain Tumor, Brain Tumor - Metastatic, Brain Tumor, Adult Meningioma | 2 |
| Midwest Cornea Associates | Neurotrophic Keratitis | 2 |
| Urology of Indiana | Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-Muscle Invasive Bladder Neoplasms | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 2 |
| Retina Partners Midwest, P.C. | Age - Related Macular Degeneration (AMD), Geographic Atrophy (GA), Age-Related Macular Degeneration | 2 |
| Urology of Indiana - Carmel | High-Risk Non-Muscle-Invasive Bladder Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms | 2 |
| Ascension St. Vincent | Aortic Aneurysm, Aortic Dissection, Intramural Hematoma | 1 |
| Ascension St. Vincent Hospital Indianapolis Goodman Campbell Brain and Spine | Intracranial Aneurysm | 1 |
| Associated Vitreoretinal & Uveitis Consultants - Carmel | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 1 |
| CBCC Global Research Site:004 | Age-related Wet Macular Degeneration | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Glaukos Investigative Site | Persistent Corneal Epithelial Defect | 1 |
| Goodman Campbell Brain and Spine/Ascension | Traumatic Brain Injury | 1 |
| IU Health Beltway Surgery Center | Lumbar Spinal Stenosis | 1 |
| IU Health North / Schwarz Cancer Center | Metastatic Cancer | 1 |
| IU Health Schwarz Cancer Center | Dyspareunia, Pelvic Pain, Radiation Toxicity | 1 |
Active & Upcoming Studies in Carmel (2026)
Recruiting trials in Carmel grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (38 active studies)
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
- Pilot Randomized Clinical Trial of Informational Support Versus Spiritual Care · Indiana University
Eye & vision (18 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Neurology & pain (3 active studies)
- Rapid Evacuation and Access of Cerebral Hemorrhage Trial · Emory University
- PerQdisc Traditional Feasibility Trial. · Spinal Stabilization Technologies
Cardiovascular (3 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities · Phase 3 · Weill Medical College of Cornell University
Diabetes & metabolic (1 active study)
Common conditions studied in Carmel
- Breast Cancer (5 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Geographic Atrophy (3 active studies). Recruiting Geographic Atrophy studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Geographic Atrophy Secondary to Age-related Macular Degeneration (3 active studies). Recruiting Geographic Atrophy Secondary to Age-related Macular Degeneration studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Age-Related Macular Degeneration (2 active studies). Recruiting Age-Related Macular Degeneration studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Carmel
- Indiana University
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- National Cancer Institute (NCI)
Local regulations and guidelines
Clinical trials in Indiana are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Indiana research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Carmel. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Carmel
Hipa.ai aggregates every recruiting study in Carmel from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Carmel?
There are approximately 89 recruiting clinical trials in Carmel, Indiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Carmel pay participants?
Most recruiting trials in Carmel compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Carmel?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Carmel?
The most common conditions under active study in Carmel include Breast Cancer (5), Anatomic Stage II Breast Cancer AJCC v8 (3), Geographic Atrophy (3), Geographic Atrophy Secondary to Age-related Macular Degeneration (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Carmel?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Carmel on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Carmel?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Carmel?
Recruiting research sites in Carmel include IU Health North Hospital, Midwest Eye Institute, IU Health Joe and Shelly Schwarz Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Carmel right now?
The largest active categories in Carmel are Cancer & tumors (38), Eye & vision (18), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.